Active, not recruiting
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
NCT03032406
- Conditions
- Breast Cancer Stage IIB, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States